APR-DRG 011-2

Chimeric antigen receptor (CAR) T-cell and other immunotherapy treatment at UPMC Magee-Womens Hospital

Hospitals report these codes with terse, inconsistent chargemaster text. This plain-English title was written by an AI model from that text and has not been reviewed by a person, so it can be wrong. The prices on this page come straight from hospital filings and do not depend on it.

Model: claude-haiku-5-5
Provider: anthropic
API: message_batches
Reasoning effort: low
Max output tokens: 4096
Prompt version (hash): 41efcec26401
Generated: October 17, 2026

Original text from hospital filings

APR-DRG 42.00: CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL AND OTHER IMMUNOTHERAPIES

Pittsburgh, PA

See all hospitals reporting APR-DRG 011-2 →

SharePost on X LinkedIn

Pricing by billing methodology

Price type

How this price compares nationally

UPMC Magee-Womens Hospital’s median price of $244.2k is 194% above the median hospital's median price ($83.0k), higher than 90% of the 578 hospitals reporting APR-DRG 011-2. The highlighted bar is where this hospital falls; shaded is the middle 50% of hospitals.

Last updated: Mar 6, 2026

Compare to other hospitals

See Chimeric antigen receptor (CAR) T-cell and other immunotherapy treatment pricing across every hospital in the network reporting it, or ask Claude or any MCP client directly — see how to connect.